Bone Biologics (BBLGW) Accumulated Expenses (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Accumulated Expenses for 2 consecutive years, with $191667.0 as the latest value for Q3 2017.
- Quarterly Accumulated Expenses changed N/A to $191667.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $191667.0 through Sep 2017, changed N/A year-over-year, with the annual reading at $41667.0 for FY2016, N/A changed from the prior year.
- Accumulated Expenses for Q3 2017 was $191667.0 at Bone Biologics, up from $141667.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $191667.0 in Q3 2017, with the low at $41667.0 in Q4 2016.